Elaine Shum
9PUBLICATIONS
148CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Oct 30, 2025
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors.Kristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem
|Sep 09, 2025
Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B).James Chih-Hsin Yang, Mengzhao Wang, Ludovic Doucet
|Jan 06, 2025
Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study.Jacob Sands, Myung-Ju Ahn, Aaron Lisberg
|Oct 08, 2024
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve EGFR-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial).Xiuning Le, Jyoti D Patel, Elaine Shum
|Nov 21, 2023
Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT).Nitin Ohri, Shruti Jolly, Benjamin T Cooper
Pageof 2
Frequent Collaborators
3 joint publications
Pasi A Jänne
3 joint publications
Xiuning Le
2 joint publications
Bruna Pellini
2 joint publications
Enriqueta Felip
2 joint publications
Sunmin Lee
2 joint publications
John V Heymach
2 joint publications
Jyoti D Patel
2 joint publications
Luis Paz-Ares Rodriguez
2 joint publications
David Planchard
2 joint publications
Joshua Sabari